Paper6202829
Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses.
Löwer R and 4 others. J Gen Virol, 1984. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. Papers, record 6202829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6202829
- Cell line
- Tera-213 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Retroviridae | Major topic |
| Teratoma | Major topic |
| Antigens, Viral | |
| Cell Division | |
| Culture Techniques | |
| Humans | |
| Microscopy, Electron | |
| RNA-Directed DNA Polymerase | |
| Virus Replication |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42026652 | HERV-K HML-2 transcriptional profiling and splicing pattern unveiled by direct single-molecule long-read RNA sequencing. | Mob DNA | 2026 | https://conductscience.org/library/papers/42026652 | PubMed |
| 38916727 | Endogenous Retroviruses Unveiled: A Comprehensive Review of Inflammatory Signaling/Senescence-Related Pathways and Therapeutic Strategies. | Aging Dis | 2024 | https://conductscience.org/library/papers/38916727 | PubMed |
| 38655281 | Beyond pathogens: the intriguing genetic legacy of endogenous retroviruses in host physiology. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38655281 | PubMed |
| 37834078 | Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834078 | PubMed |
| 37596282 | Reactivated endogenous retroviruses promote protein aggregate spreading. | Nat Commun | 2023 | https://conductscience.org/library/papers/37596282 | PubMed |
| 36256614 | Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues. | PLoS Biol | 2022 | https://conductscience.org/library/papers/36256614 | PubMed |
| 35801347 | Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic. | Ann Neurol | 2022 | https://conductscience.org/library/papers/35801347 | PubMed |
| 34830279 | A Comprehensive Analysis of Human Endogenous Retroviruses HERV-K (HML.2) from Teratocarcinoma Cell Lines and Detection of Viral Cargo in Microvesicles. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830279 | PubMed |
| 32640516 | Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target. | Viruses | 2020 | https://conductscience.org/library/papers/32640516 | PubMed |
| 31333597 | Interferon-Inducible Protein 16 (IFI16) Has a Broad-Spectrum Binding Ability Against ssDNA Targets: An Evolutionary Hypothesis for Antiretroviral Checkpoint. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31333597 | PubMed |
| 31269986 | Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR. | Acta Neuropathol Commun | 2019 | https://conductscience.org/library/papers/31269986 | PubMed |
| 30318978 | Human endogenous retrovirus-K (HML-2): a comprehensive review. | Crit Rev Microbiol | 2018 | https://conductscience.org/library/papers/30318978 | PubMed |
| 29706951 | Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. | Front Immunol | 2018 | https://conductscience.org/library/papers/29706951 | PubMed |
| 29046457 | HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements. | J Virol | 2018 | https://conductscience.org/library/papers/29046457 | PubMed |
| 27640347 | A contaminant-free assessment of Endogenous Retroviral RNA in human plasma. | Sci Rep | 2016 | https://conductscience.org/library/papers/27640347 | PubMed |
| 26792739 | Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein. | J Virol | 2016 | https://conductscience.org/library/papers/26792739 | PubMed |
| 25927962 | Genome-wide amplification of proviral sequences reveals new polymorphic HERV-K(HML-2) proviruses in humans and chimpanzees that are absent from genome assemblies. | Retrovirology | 2015 | https://conductscience.org/library/papers/25927962 | PubMed |
| 25746218 | Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1. | Viruses | 2015 | https://conductscience.org/library/papers/25746218 | PubMed |
| 25112280 | The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls. | Retrovirology | 2014 | https://conductscience.org/library/papers/25112280 | PubMed |
| 25056891 | HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. | J Virol | 2014 | https://conductscience.org/library/papers/25056891 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6202829
GET https://conductscience.org/api/papers/v1/6202829/cited_by?page=2